Semaglutide works only on the GLP-1 pathway, while Tirzepatide targets both GLP-1 and GIP pathways, often leading to greater weight loss
Due to their popularity, GLP-1 medications can sometimes be in short supply
Cannabidiol for neurodegenerative disorders: A comprehensive review
Zafereo ME , Jozaghi Y, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH
Clinics and medspas throughout Denver offer both Mounjaro and compounded Tirzepatide, often as part of comprehensive weight loss programs that include nutrition guidance and lifestyle coaching
Patients considering HCG should understand that its typically not a first-line option in 2024-2026 compared with the more robust evidence base supporting GLP-1 and GIP-GLP-1 therapies